# US 2012/0059158 A1 · Steroid compound

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0059158 A1
- Document ID: US20120059158A1
- Status: Published application
- Kind: A1
- Application number: 13/255,820
- Filed: 2010-03-08
- Published: 2012-03-08
- Earliest claimed: 2009-03-09
- Assignees: Mikasa Seiyaku Co., Ltd.
- Inventors: Takayuki Ishii
- Web page: https://patentgrep.com/patent/US20120059158A1

## CPC

- C07H 15/24: Condensed ring systems having three or more rings
- A61P 1/04: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A61P 11/02: Nasal agents, e.g. decongestants
- A61P 11/06: Antiasthmatics
- A61P 17/00: Drugs for dermatological disorders
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 27/02: Ophthalmic agents
- A61P 27/14: Decongestants or antiallergics
- A61P 27/16: Otologicals
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C07J 71/0031: {at positions 16, 17}
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07J: STEROIDS (seco-steroids C07C)

## Abstract

A steroid compound of the Formula (1): [wherein R1 represents a group selected from the group consisting of H, CH3, C2H5, C3H7 and CH (CH3)2, R2 represents a group selected from NH2, NHAc and OCOR1, R3 represents a group selected from the group consisting of CH3, COOCH3 and CH2OCOR1.]

## Claims

### Claim 1

A steroid compound of the Formula (I):
[wherein R1 represents a group selected from the group consisting of H, CH3, C2H5, C3H7 and CH (CH3)2, R2 represents a group selected from NH2, NHAc and OCOR1, R3 represents a group selected from the group consisting of CH3, COOCH3 and CH2OCOR1.]

### Claim 2 (depends on 1)

The compound according to claim 1, wherein R2 is OCOR1 and R3 is CH2OCOR1.

### Claim 3 (depends on 1, 2)

The compound according to claim 1 or 2, wherein R1 is CH3.

### Claim 4 (depends on 1, 2)

The compound according to claim 1 or 2, wherein said R1 is H.

### Claim 5 (depends on 1, 2)

The compound according to claim 1 or 2, wherein said R1 is C2H5.

### Claim 6 (depends on 1, 2, 3, 4, 5)

An anti-inflammatory agent comprising as an effective ingredient the compound according to any one of claims 1 to 5.

### Claim 7 (depends on 6)

The anti-inflammatory agent according to claim 6, which is an external preparation.

### Claim 8 (depends on 7)

The anti-inflammatory agent according to claim 7, which is a therapeutic agent for asthma to be administered by inhalation, a therapeutic agent for allergic rhinitis to be administered by intranasal administration, a therapeutic agent for arthritis or dermatitis to be administered by topical application, or a therapeutic agent for external ocular inflammatory diseases to be administered by instillation.

### Claim 9 (depends on 1, 2, 3, 4, 5)

An arthritis therapeutic agent, comprising as an effective ingredient the compound according to any one of claims 1 to 5.

### Claim 10 (depends on 1, 2, 3, 4, 5)

A therapeutic agent for ulcerative colitis, comprising as an effective ingredient the compound according to any one of claims 1 to 5.
